(Q34156824)

31 July 2017

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? (English)

1 reference

primary progressive multiple sclerosis

31 July 2017

0 references

multiple sclerosis

0 references

author name string

Jack Antel

1

1 reference

31 July 2017

Samson Antel

2

1 reference

31 July 2017

Zografos Caramanos

3

1 reference

31 July 2017

Douglas L Arnold

4

1 reference

31 July 2017

Tanja Kuhlmann

5

1 reference

31 July 2017

11 February 2012

1 reference

31 July 2017

Acta Neuropathologica

1 reference

31 July 2017

123

1 reference

31 July 2017

627-638

1 reference

31 July 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-012-0953-0

31 July 2017

0 references

cites work

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Extensive cortical remyelination in patients with chronic multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Axonal loss in normal-appearing white matter in a patient with acute MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Demyelination versus remyelination in progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Cortical lesions in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Multiple sclerosis in sibling pairs: an analysis of 250 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Age at disability milestones in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Remyelination capacity of the MS brain decreases with disease chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Progressive multiple sclerosis: characteristics and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Primary progressive multiple sclerosis: a 5-year clinical and MR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

The pathologic substrate of magnetic resonance alterations in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Stem cell transplantation in multiple sclerosis: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Diagnosis and classification of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Multiple sclerosis: a complicated picture of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Remyelination can be extensive in multiple sclerosis despite a long disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Remyelination is extensive in a subset of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Primary and transitional progressive MS: a clinical and MRI cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-012-0953-0

10.1007/S00401-012-0953-0

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference